Login/Sign Up
Arzerra 1000mg Solution for Infusion
Arzerra 1000mg Solution for Infusion is used to treat Chronic Lymphocytic Leukemia and Multiple sclerosis. It contains Ofatumumab, which works by inhibiting the B-cell lymphocytes that are responsible for the multiplication of cancer cells; this causes shrinkage of tumour cells and thereby prevents the growth and further spread of cancerous or non-cancerous cells. Arzerra 1000mg Solution for Infusion may cause certain side effects, such as nausea, vomiting, diarrhoea, fever, decreased platelet count, fatigue, cough, insomnia, injection site reactions and pain at the site of injection.
₹138186.4*
MRP ₹168520
18% off
₹143242*
MRP ₹168520
15% CB
₹25278 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Arzerra 1000mg Solution for Infusion is an anti-cancer medicine used in the treatment of cancer. The intravenous route of this medicine is used in combination with chlorambucil for the treatment of CLL in patients for whom fludarabine-based therapy is considered inappropriate and as an extended treatment in patients who have a partial response after at least two lines of therapy. Chronic lymphocytic leukaemia is a cancer that occurs in the bone marrow and blood. The subcutaneous route of the medicine is used in treating relapsing forms of multiple sclerosis. It is a condition in which the immune system attacks the protective covering of the nerves called myelin.
Arzerra 1000mg Solution for Infusion contains Ofatumumab, which belongs to the class of monoclonal antibodies. It works by inhibiting the B-cell lymphocytes that are responsible for the multiplication of cancer cells.
Arzerra 1000mg Solution for Infusion may cause certain side effects, such as nausea, vomiting, diarrhoea, fever, decreased platelet count, fatigue, cough, insomnia, injection site reactions and pain at the site of injection. If the side effects bother you, inform your doctor. A trained healthcare professional will administer Arzerra 1000mg Solution for Infusion. Hence, do not self-administer.
While taking Arzerra 1000mg Solution for Infusion if you experience any allergic reaction, inform your doctor. Before receiving this injection, inform your doctor if you have any pre-existing or a history of liver/kidney disease, active infections, skin problems, or any allergic conditions. Arzerra 1000mg Solution for Infusion is known to cause fetal B-cell depletion in neonates. Hence, inform your physician if you are pregnant beforehand. Breastfeeding mothers should avoid taking Arzerra 1000mg Solution for Infusion.
Arzerra 1000mg Solution for Infusion contains Ofatumumab, which belongs to the class of CD20-directed cytolytic antibodies. It is used in the treatment of chronic lymphocytic leukaemia. This medicine works by binding to the CD20 antibody and causes lysis of B-cell lymphocytes responsible for the multiplication of cancer cells. This causes shrinkage of tumour cells and thereby prevents the growth and further spread of cancerous or non-cancerous cells.
For Chronic Lymphocytic leukemia:
For Multiple Sclerosis:
Arzerra 1000mg Solution for Infusion should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. Before receiving this injection, inform your doctor if you have any history of liver/kidney disease, active infections, skin problems, or any allergic conditions. Arzerra 1000mg Solution for Infusion may cause remission of active infections, severe skin reactions, tumour lysis syndrome (tumour cells release their contents into the bloodstream), hepatitis B virus reactivation, progressive multifocal leukoencephalopathy, and hypersensitivity reactions in some patients. Hence, careful monitoring should be done during the entire treatment. Arzerra 1000mg Solution for Infusion may cause fetal B-cell depletion in infants. Hence, if you are pregnant or planning to become pregnant, inform your doctor beforehand. Before nursing, a breastfeeding mother should ask her oncologist whether this medicine is safe for use or not. Arzerra 1000mg Solution for Infusion is not recommended for use in children as the safety and efficacy are not established.
Drug-Drug Interactions: No interactions found.
Drug-Food Interactions: Avoid alcohol consumption and smoking.
Drug-Disease Interactions: Inform your doctor if you have kidney or liver disease, skin diseases, and infections before receiving Arzerra 1000mg Solution for Infusion.
Chronic Lymphocytic Leukaemia: It is a type of cancer that occurs in the bone marrow and blood. It increases the number of lymphocytes (a type of white blood cell). The symptoms include fever, enlarged liver, bone or joint pain, shortness of breath, weakness, and bleeding from gums or bruises.
Multiple sclerosis: Multiple sclerosis is a condition that affects the brain and spinal cord. The immune system attacks the protective covering of the nerves (myelin) and causes disrupted communication between the brain and body due to nerve damage. This causes symptoms such as problems with sensation, balance, vision, pain, impaired coordination, and fatigue.
Alcohol
Consult your doctor
It is unknown whether Arzerra 1000mg Solution for Infusion interacts with alcohol. Consult your doctor.
Pregnancy
Unsafe
Arzerra 1000mg Solution for Infusion is not recommended for use in pregnancy as it may cause fatal B-lymphocyte depletion in your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Arzerra 1000mg Solution for Infusion.
Breast Feeding
Caution
If you are breastfeeding, inform your doctor before receiving Arzerra 1000mg Solution for Infusion. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Driving
Caution
Arzerra 1000mg Solution for Infusion will be administered in the hospital setting. Hence, driving is not recommended.
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before receiving Arzerra 1000mg Solution for Infusion. Arzerra 1000mg Solution for Infusion may cause increased bilirubin levels and liver failure. Hence, inform your doctor if you observe any symptoms such as fatigue, yellow discolouration of eyes, and dark coloured urine. A dose adjustment of this medicine or a suitable alternative may be advised based on your condition. A dose adjustment of this medicine or a suitable alternative may be advised based on your condition.
Kidney
Caution
If you have a pre-existing or a history of kidney disease, inform your doctor before receiving Arzerra 1000mg Solution for Infusion. A dose adjustment of this medicine or a suitable alternative may be advised based on your condition.
Children
Unsafe
Arzerra 1000mg Solution for Infusion is not recommended for use in children as the safety and efficacy are not established.
Country of origin